Skip to main content
. 2023 Apr 6;40(6):1491–1505. doi: 10.1007/s11095-023-03494-0

Table X.

Number of Formulations with Light and Temperature Sensitivity Indication by Dosage Form

Dosage From Total Formulations (n = 557) Protect from Light Do Not Freeze
Indication No Indication Indication No Indication
Solid (oral) 11 (1.97%) 0 (0.00%) 11 (100.0%) 0 (0.00%) 11 (100.0%)
Lyophilized powder 154 (27.65%) 88 (57.14%) 66 (42.86%) 86 (55.84%) 68 (44.16%)
Liquid 389 (69.84%) 371 (95.37%) 18 (4.63%) 363 (93.32%) 26 (6.68%)
Topical 3 (0.54%) 0 (0.00%) 3 (100.0%) 1 (33.33%) 2 (66.67%)